Skip to content
Screener

Precigen PGEN Total Current Liabilities

Total Current Liabilities at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$18.66B-32.2%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$5.53B+50.8%
Gilead Sciences logo
Gilead SciencesGILD
$11.02B-1.5%
Allogene Therapeutics logo
Allogene TherapeuticsALLO
$28.33M-5.6%
Apogee Therapeutics, Inc. logo
Apogee Therapeutics, Inc.APGE
$32.95M0.0%
Regenxbio logo
RegenxbioRGNX
$82.62M-30.9%

Other financials

Income statement

See full
Revenue$23.3M+1,634%
Operating income-$6.0M+73.5%
Net income-$7.9M+85.4%
EPS (diluted)-$0.02+88.9%

Balance sheet

See full
Cash & equivalents$7.5M+23.5%
Total debt$98.3M+1,714%
Total equity$20.2M+244%
Total assets$138.6M+7.6%

Cash flow

See full
Operating cash flow-$43.8M-168%
CapEx$258.0K-58.5%
Free cash flow-$44.1M-160%

Valuation

See full
Market cap$2.47B+358%
Enterprise value$2.56B+382%
P/S93.2×

Profitability

See full
Gross margin83.6%
Operating margin-2,890.9%
Net margin-3,656%
FCF margin-1,756.5%

Returns & leverage

See full
Return on equity-843.6%-1,103pp
Debt / equity4.9×
Current ratio4.8×+1.3×

Where this comes from

Reported directly by Precigen in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.

The source filing: Precigen’s 10-Q, filed May 13, 2026.

Filed
May 13, 2026, 4:20 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001356090-26-000017
(Amounts in thousands, except share data)March 31,2026December 31,2025
Indemnification accruals2,476
Deferred revenue410517
Current portion of lease liabilities1,0681,136
Total current liabilities21,10437,306
Long-term debt93,51993,174
Lease liabilities, net of current portion3,6633,980
Other long-term liabilities106134
Total liabilities118,392134,594

Item 1. Condensed Consolidated Financial Statements

FAQ

What is Precigen's total current liabilities?
Precigen (PGEN) reported total current liabilities of $21.1M in Q1 2026.
How has Precigen's total current liabilities changed year-over-year?
Precigen's total current liabilities decreased by 12.0% year-over-year, from $23.99M to $21.1M.
What is the long-term trend for Precigen's total current liabilities?
Over 5 years (2020 to 2025), Precigen's total current liabilities has grown at a -2.4% compound annual growth rate (CAGR), from $42.13M to $37.31M.
What does total current liabilities mean?
The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.

Ask your AI about Precigen's total current liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude